Highbridge Capital Management’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
KCM
Highbridge Capital Management's GOSS Position: Q3 2026 in Review
Highbridge Capital Management opened a new position in Gossamer Bio (GOSS) in Q3 2026: 75,697 shares worth $877K. The stake represents 0.02% of the portfolio and ranks #240 among its holdings. This is a return to the name: Highbridge Capital Management previously reported a position in GOSS as recently as Q2 2025.
Highbridge Capital Management first reported a position in GOSS in Q3 2023 and has held it in 9 quarters since. The position peaked at $2.52M in Q3 2023. 57 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.
- Highbridge Capital Management held 75,697 shares of Gossamer Bio worth $877K as of Q3 2026.
- Gossamer Bio was a new Highbridge Capital Management position in Q3 2026.
- Gossamer Bio made up 0.02% of Highbridge Capital Management's portfolio in Q3 2026, its #240 holding.
- Highbridge Capital Management first reported a position in Gossamer Bio in Q3 2023 and has held it in 9 quarters since.
- Highbridge Capital Management's Gossamer Bio position peaked at $2.52M in Q3 2023.
- 57 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.
Based on Highbridge Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.